Congenital Heart Disease
536
82
98
260
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
44 trials with published results (8%)
Research Maturity
260 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
34 terminated out of 536 trials
88.4%
+1.8% vs benchmark
4%
19 trials in Phase 3/4
17%
44 of 260 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 260 completed trials
Clinical Trials (536)
The Effect of Telerehabilitation Exercises in Children With Congenital Heart Disease
The Genetic Basis of Congenital Heart Disease in Africa
Harmony TPV Post-Approval Study
Exercise Prehabilitation in Congenital Heart Disease
Autus Valve Pivotal Study
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
TORCH-LATAM-003: Regional Advanced-Therapy Pathways for Congenital Heart Disease
PDA for Kidneys Study
Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)
Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
Perinatal Cardiology: Bridging Obstetric and Neonatal Care in CHD
Pulmonary Determinants of Cardiorespiratory Fitness in Fontan Patients
International Multicenter Outcomes of Transcatheter Pulmonary Flow Restrictors in Congenital and Acquired Heart Disease
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
TORCH-LATAM: A Regional Pathway to Improve Transplant Evaluation for Congenital Heart Disease
HEARTPrep: A Virtually-delivered Psychosocial Intervention for Mothers Expecting a Baby With Congenital Heart Disease
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Heart2Heart for Teens With CHD